1.Development of PCR Technology for Identification of the Restriction Fragment Length Polymorphism(RFLP) of the Immunoglobulin Allotypes in Periodontal Patients.
Jeom Il CHOI ; Sung Jo KIM ; In Hoo KIM
The Journal of the Korean Academy of Periodontology 1999;29(2):349-354
The present study has been performed to develop a PCR technology to identify human immunoglobulin(Ig) allotypes with restriction fragment length polymorphism(RFLP) using a probe. Genomic DNA were ampilified with PCR tecnology using primers from peripheral blood lymphocytes of 10 periodontal patiens, whose Ig allotypes have been pre-determined by serological tecnique using heagglutination technique. The result indicated that the RFLP patterns could successfully differentiate the Ig allotypes, which suggests that this technology can be developed as a tool useful for population genetics studies.
DNA
;
Genetics, Population
;
Humans
;
Immunoglobulin Allotypes*
;
Immunoglobulins*
;
Lymphocytes
;
Polymerase Chain Reaction*
;
Polymorphism, Restriction Fragment Length
2.Porokeratosis Ptychotropica: A Lesser-known Variant of Porokeratosis
Hoo Min CHOI ; Sung Min KIM ; Jae Won KANG ; Byung In RO ; Han Kyoung CHO
Korean Journal of Dermatology 2019;57(9):562-563
No abstract available.
Porokeratosis
3.Expression of intercellular adhesion molecule-1 in human primary lung cancers.
Young Chun CHOI ; Dong Ho SHIN ; Sung Soo PARK ; Dong Hoo LEE ; Jung Hee LEE ; Jung Dal LEE
Korean Journal of Medicine 1993;45(4):467-472
No abstract available.
Humans*
;
Intercellular Adhesion Molecule-1*
;
Lung Neoplasms*
;
Lung*
4.A Case of Superficial Spreading Capillary Hemangioma.
Suk young LEE ; Jong Baik KIM ; Hoo Min CHOI ; Sung Min KIM ; Eun Jung KO ; Byung In RO ; Han Kyoung CHO
Korean Journal of Dermatology 2018;56(6):396-397
No abstract available.
Capillaries*
;
Hemangioma, Capillary*
5.A Case of Palmoplantar Keratoderma Presenting as Multiple Cutaneous Horns.
Hoo Min CHOI ; Jong Baik KIM ; Suk Young LEE ; Sung Min KIM ; Eun Jung KO ; Byung In RO ; Han Kyoung CHO
Korean Journal of Dermatology 2018;56(9):562-564
No abstract available.
Animals
;
Horns*
;
Keratoderma, Palmoplantar*
6.Verruca Plana Developed after Tattooing
Sung Min KIM ; Jong Baik KIM ; Hoo Min CHOI ; Byung In RO ; Han Kyoung CHO ; Eun Jung KO
Korean Journal of Dermatology 2019;57(3):168-169
7.Two Cases of Emphysematous Cystitis.
Joo Ik PARK ; Joo Myeong SHIM ; Seong Yoon JUNG ; Young Hoo SEO ; Jae Il JUNG ; Ho Cheol CHOI ; Sung Hyup CHOI ; Heon Sung LEE
Korean Journal of Urology 2000;41(8):1033-1095
No abstract available.
Cystitis*
8.Quantitation of BK Virus DNA for Diagnosis of BK Virus-Associated Nephropathy in Renal Transplant Recipients.
Heungsup SUNG ; Byung Hoo CHOI ; Yeon Jung PYO ; Mi Na KIM ; Duck Jong HAN
Journal of Korean Medical Science 2008;23(5):814-818
Quantitative measurement of BK virus DNA (Q-BKDNA) has been used for the early diagnosis and monitoring of BK virus-associated nephropathy (BKVAN). This study was designed to determine the BKDNA cutoff for the diagnosis of BKVAN. Between June 2005 and February 2007, 64 renal transplant recipients taken renal biopsies due to renal impairment submitted plasma and urine for Q-BKDNA. Eight BKVAN patients (12.5%) had median viral loads of 6.0 log(10) copies/mL in plasma and 7.3 log(10) copies/mL in urine. Among 56 non-BKVAN patients, 45 were negative for Q-BKDNA; 4 were positive in plasma with a median viral load of 4.8 log(10) copies/ mL, and 10 were positive in urine with a median viral load of 4.8 log(10) copies/mL. Receiver operating characteristic curve analysis showed that a cutoff of 4.5 log(10) copies/mL in plasma and a cutoff of 5.9 log(10) copies/mL in urine had a sensitivity of 100% and a specificity of 96.4%, respectively. A combined cutoffs of 4 log(10) copies/ mL in plasma and 6 log(10) copies/mL in urine had better performance with a sensitivity of 100% and a specificity of 98.2% than each cutoff of urine or plasma. QBKDNA with the combined cutoffs could reliably diagnose BKVAN in renal transplant recipients.
Adolescent
;
Adult
;
BK Virus/*genetics
;
Biopsy
;
Calibration
;
DNA, Viral/*genetics
;
Female
;
Humans
;
Kidney Diseases/*virology
;
Kidney Transplantation/*methods
;
Male
;
Middle Aged
;
Polymerase Chain Reaction
;
Polyomavirus Infections/diagnosis
;
Treatment Outcome
9.Outcome after Partial Hepatectomy for Hepatocellular Carcinoma Combined with Liver Cirrhosis.
Sung Jin KIM ; Sang Beom KIM ; Sun Hoo PARK ; Dong Wook CHOI
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2003;7(1):61-68
BACKGROUND/AIMS: Partial hepatectomy is considered as best treatment for selected HCC patients combined with liver cirrhosis. We conducted this study to assess the safety and effects of partial hepatectomy for HCC combined with liver cirrhosis and to identify the prognostic factors. METHODS: Retrospective analysis was performed for 115 HCC patients with liver cirrhosis who underwent hepatectomy in Korea Cancer Center Hospital from 1987 September to 2002 July. Median follow-up period was 30 months. RESULTS: In-hospital mortality rate was 0.87% (1/115 cases). 5-years overall and disease free survival rates were 59.3% and 44.75%, respectively. Fifty three patients developed recurrence and most common recurrent site was remnant liver (81.1%) and 3-year survival rate after recurrence was 33.4%. Independent prognostic factors for overall survival rate were TNM stage, multiplicity and venous invasion (p<0.05). CONCLUSION: Hepatectomy plays a significant role for HCC with compensated liver cirrhosis and is regarded as the effective treatment with acceptable mortality. However, recurrence rate is still high, so frequent follow-up study should be needed for early detection of recurrence amenable to effective treatment. For the high risk patients, further study should be followed to reduce the recurrence after hepatectomy, including surgical technique and adjuvant treatment.
Carcinoma, Hepatocellular*
;
Disease-Free Survival
;
Follow-Up Studies
;
Hepatectomy*
;
Hospital Mortality
;
Humans
;
Korea
;
Liver Cirrhosis*
;
Liver*
;
Mortality
;
Recurrence
;
Retrospective Studies
;
Survival Rate
10.Churg-Strauss Syndrome Presented With Hearing Impairment and Facial Palsy.
Jeong Hyun BYUN ; Jong Hoo LEE ; In Sung CHOI
Annals of Rehabilitation Medicine 2014;38(6):852-855
Churg-Strauss syndrome (CSS) is a rare systemic necrotizing vasculitis. Cranial nerve involvement is very rare in CSS. A 59-year-old woman had complained of both hearing impairments for eight months and left facial palsy for three months. Left facial and cochlear neuropathies were detected in electrodiagnostic studies. Paranasal sinus computed tomography (CT) showed chronic pansinusitis. Chest CT revealed eosinophilic infiltration in the right upper lobe. Tissue biopsy of the right inferior turbinate displayed necrotizing vasculitis with eosinophilic infiltration. She was diagnosed as CSS, based on the presence of eosinophilia, pulmonary infiltration, paranasal sinusitis, and biopsy containing blood vessels with extravascular eosinophils. She was treated with intravenous and oral steroids and azathioprine, showing relatively good prognosis on facial palsy and hearing impairment. We report a very rare case of CSS presented with hearing impairment and facial palsy.
Azathioprine
;
Biopsy
;
Blood Vessels
;
Churg-Strauss Syndrome*
;
Cranial Nerves
;
Eosinophils
;
Facial Paralysis*
;
Female
;
Hearing
;
Hearing Loss*
;
Humans
;
Middle Aged
;
Prognosis
;
Pulmonary Eosinophilia
;
Sinusitis
;
Steroids
;
Tomography, X-Ray Computed
;
Turbinates
;
Vasculitis